Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPensionbee Regulatory News (PBEE)

Share Price Information for Pensionbee (PBEE)

Share Price is delayed by 15 minutes
Get Live Data
138.00    2.00 (1.47%)
Bid:
136.50
Ask:
138.00
Spread: 1.50 (1.099%)
Market Cap: £329.35m
PBEE Live PriceLast checked at - London Stock Exchange

Intraday Pensionbee Share Chart

Equity Raise Post-Transaction Report

28 Oct 2024 09:57

RNS Number : 8728J
PensionBee Group plc
28 October 2024
Β 

PensionBee Group plc

Incorporated in England and Wales

Registration Number: 13172844

LEI: 2138008663P5FHPGZV74

ISIN: GB00BNDRLN84

Β 

28 October 2024

PensionBee Group plc

Equity Raise Post-Transaction Report

In accordance with the Statement of Principles (November 2022) published by the Pre-Emption Group, PensionBee Group plc ('PensionBee' or the 'Company'), announces the following post transaction report in connection with the Company's non-pre-emptive issue of equity securities, as announced on 24 October 2024.

Β 

Terms defined in the placing announcement issued on 23 October 2024 (the 'Placing Announcement') have the same meanings in this announcement unless the context provides otherwise.

Β 

Name of Issuer

PensionBee Group plc

Transaction Details

The Company issued 10,810,811 new ordinary shares in total pursuant to the Placing, representing approximately 4.8% of the Company's existing issued ordinary shares prior to the Placing.

Settlement and admission of the Placing Shares took place at 8.00 am on 28 October 2024.

Use of Proceeds

As set out in the Placing Announcement the proceeds of the Placing (net of transaction costs) will be used to accelerate the delivery of the Company's medium and long term guidance, through investment in its US business.

Quantum of Proceeds

The aggregate gross proceeds from the Placing amounted to approximately Β£20 million.

Discount

The Placing Price of 185 pence represented no discount to the closing price on 23 October 2024.

Allocations

Soft pre-emption has been adhered to in the allocations process, where possible. Management was involved in the allocations process, which has been carried out in compliance with the MIFID II Allocation requirements.

Consultation

KBW and the Company undertook a pre-launch wall-crossing process, including consultation with certain major shareholders, to the extent reasonably practicable and permitted by law.

Retail Investors

Following discussions between KBW and the Company, it was decided that a retail offer would not be included in the Placing. The Placing structure was chosen to minimise cost, time to completion and complexity.

Β 

Enquiries: PensionBee

Becky O'Connor

Laura Dunn-Sims

Steven Kennedy

press@pensionbee.com

Β 

KBW, a Stifel Company

Alistair McKay

Alberto Moreno Blasco

Erik Anderson

Nick Harland

Β 

About PensionBee

PensionBee is creating a global leader in the consumer retirement market with Β£5.5 billion in assets on behalf of 260,000 customers.

Founded in 2014, we aspire to make as many people as possible pension confident so that everyone can enjoy a happy retirement.

We help our customers to combine their retirement savings into a new online account, which they can manage from the palm of their hand.

PensionBee accounts are invested by the world's largest investment managers, collectively looking after more than $10 trillion in savings between them. Each PensionBee customer has a personal account manager ("BeeKeeper") to guide them through their savings and retirement journey. PensionBee has an "Excellent" Trustpilot rating based on over 10,000 reviews.

As a public company, we aspire to the highest standards in everything we do because our customers deserve peace of mind. Our team of approximately 200 pension professionals, based in London and New York, has one focus: you, our customer.

PensionBee is listed on the London Stock Exchange (LON:PBEE).

Forward Looking Statements

Statements that are not historical facts, including statements about PensionBee's or management's beliefs and expectations, are forward-looking statements. The results contain forward-looking statements, which by their nature involve substantial risks and uncertainties as they relate to events and depend on circumstances which will occur in the future and actual results and developments may differ materially from those expressly stated or otherwise implied by these statements.

These forward-looking statements are statements regarding PensionBee's intentions, beliefs or current expectations concerning, among other things, its results of operations, financial condition, prospects, growth, strategies and the industry and markets within which it operates.

These forward-looking statements relate to the date of these results and PensionBee does not undertake any obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date of the results.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
STRGCBDGUUDDGSI
Date   Source Headline
26th Apr 20242:17 pmRNSHolding(s) in Company
26th Apr 20242:09 pmRNSBlock listing Interim Review
24th Apr 20244:30 pmRNSQ1 2024 Trading Update
24th Apr 20242:08 pmRNSHolding(s) in Company
12th Apr 202410:39 amRNSTotal Voting Rights
11th Apr 20247:30 amRNSAnnual Financial Report
25th Mar 20243:05 pmRNSDirector/PDMR Shareholding
25th Mar 20248:40 amRNSNotice of Results
15th Mar 202412:10 pmRNSHolding(s) in Company
13th Mar 20244:47 pmRNSFY 2023 Results Announcement
4th Mar 20247:00 amRNSAnnouncement of Proposed US Expansion
29th Feb 20247:00 amRNSTotal Voting Rights
5th Feb 20247:00 amRNSNotice of Results
31st Jan 20243:36 pmRNSHolding(s) in Company
31st Jan 20247:00 amRNSTotal Voting Rights
24th Jan 20244:30 pmRNS4Q 2023 Results Announcement
17th Jan 20243:26 pmRNSDirector/PDMR Shareholding
15th Jan 20249:45 amRNSHolding(s) in Company
12th Jan 202410:11 amRNSHolding(s) in Company
29th Dec 20237:00 amRNSTotal Voting Rights
27th Dec 20237:00 amRNSHolding(s) in Company
21st Dec 20237:00 amRNSNotice of Results
30th Nov 20237:00 amRNSTotal Voting Rights
10th Nov 20233:30 pmRNSPivotal Profitability Milestone Achieved
31st Oct 20237:00 amRNSTotal Voting Rights
26th Oct 20237:00 amRNSBlock listing Interim Review
19th Oct 20237:00 amRNS3Q 2023 Results Announcement
19th Sep 20237:00 amRNSNotice of Results
31st Aug 20237:00 amRNSHalf-year Report
31st Aug 20237:00 amRNSTotal Voting Rights
3rd Aug 20239:37 amRNSHolding(s) in Company
1st Aug 202312:44 pmRNSNotice of Interim Results
31st Jul 20237:00 amRNSTotal Voting Rights
20th Jul 20237:00 amRNS1H 2023 Results Announcement
30th Jun 20237:00 amRNSTotal Voting Rights
28th Jun 20233:40 pmRNSHolding(s) in Company
20th Jun 20237:00 amRNSNotice of Results
31st May 20237:00 amRNSTotal Voting Rights
18th May 20234:01 pmRNSResults of 2023 Annual General Meeting
12th May 20231:18 pmRNSDirector/PDMR Shareholding
28th Apr 20237:00 amRNSTotal Voting Rights
26th Apr 20237:00 amRNSBlock listing Interim Review
20th Apr 20237:00 amRNS1Q 2023 Results Announcement
17th Apr 202311:03 amRNSHolding(s) in Company
13th Apr 20237:05 amRNSAnnual Report 2022 and Notice of 2023 AGM
31st Mar 20237:00 amRNSTotal Voting Rights
22nd Mar 20237:00 amRNSDirector/PDMR Shareholding
21st Mar 202312:35 pmRNSNotice of Results
20th Mar 20237:00 amRNSAppointment of Joint Corporate Broker
17th Mar 20234:37 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.